Neurodegenerative Disorder-Targeting Compound 1
Neurodegenerative Disorder-Targeting Compound 1 is a calpain inhibitor extracted from patent WO2010128102A1, compound example 63[1].
Product Specifications
CAS Number
1254698-39-9
UNSPSC
12352005
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Neurodegenerative-Disorder-Targeting-Compound-1.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](CC1)N(CC2=CC=CC=C2)C1=O)NC(CC3=CC=CC=C3)C(C(NCC4=NC=CC=C4)=O)=O
Molecular Formula
C28H28N4O4
Molecular Weight
484.55
References & Citations
[1]Helmut Mack, et al. Carboxamide compounds and their use as calpain inhibitors. WO2010128102A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC043241-100 1x 100 µL
Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3241), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details ![PTP epsilon (PTPRE) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI3D4]](https://cdn.genprice.uk/products/937/68dd1b66061270361ea1448b/imageurl/ta501051am.webp)
TA501051AM 100 µL
PTP epsilon (PTPRE) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI3D4]
Sign In for Pricing
View Details 